ASX Announcements

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
September

27 Sep 2022 - Hudson Institute to Present Photosoft at Combio2022

21 Sep 2022 - Change of Director's Interest Notice - Alistair Bennallack

21 Sep 2022 - Section 708A Cleansing Statement

21 Sep 2022 - Application for quotation of securities - IVX

15 Sep 2022 - INV043 Effective Against Anal Cancer SCC In Vitro

13 Sep 2022 - Change of Director's Interest Notice - Alistair Bennallack

13 Sep 2022 - Change of Director's Interest Notice- Alan Yamashita

13 Sep 2022 - Change of Director's Interest Notice- Robert Merriel

13 Sep 2022 - Change of Director's Interest Notice - Thian Chew

13 Sep 2022 - Notification regarding unquoted securities - IVX

13 Sep 2022 - Response to ASX Aware Query

8 Sep 2022 - Photosoft Shows Activity Against Zika Virus

August

18 Aug 2022 - Appendix 4G and Corporate Governance Statement

18 Aug 2022 - Appendix 4E and Annual Report

July

21 Jul 2022 - Activities Report and Appendix 4C

June

8 Jun 2022 - International Patent to Extend IP Protection for Photosoft

May

30 May 2022 - INV043 Significantly Improved Checkpoint Inhibitor Therapy

April

20 Apr 2022 - Activities Report and Appendix 4C

March

29 Mar 2022 - Results of General Meeting

21 Mar 2022 - Change of Director's Interest Notice - Alistair Bennallack

21 Mar 2022 - Change of Director's Interest Notice- Alan Yamashita

21 Mar 2022 - Change of Director's Interest Notice- Robert Merriel

21 Mar 2022 - Change of Director's Interest Notice- Thian Chew

21 Mar 2022 - Notification regarding unquoted securities - IVX

February

25 Feb 2022 - Notice of General Meeting/Proxy Form 

22 Feb 2022 - Appendix 4D and Half Year Financial Report

03 Feb 2022 - Investor Presentation

02 Feb 2022 - Application for quotation of securities - IVX

January

20 Jan 2022 - Activities Report and Appendix 4C

December

22 Dec 2021 - Change in substantial holding

16 Dec 2021 - Top 20 Listed Option Holders

16 Dec 2021 - Appendix 2A

13 Dec 2021 - Application for quotation of securities - IVX

8 Dec 2021 - Change in substantial holding

7 Dec 2021 - Change of Director's Interest Notice - Alistair Bennallack

7 Dec 2021 - Change of Director's Interest Notice- Alan Yamashita

7 Dec 2021 - Change of Director's Interest Notice- Robert Merriel

7 Dec 2021 - Change of Director's Interest Notice- Thian Chew

7 Dec 2021 - Notification regarding unquoted securities - IVX

November

25 Nov 2021 - Proposed issue of securities - IVX

25 Nov 2021 - Supplementary Prospectus

24 Nov 2021 - Release of securities from escrow

23 Nov 2021 - Cancel - Proposed issue of securities - IVX

23 Nov 2021 - Cancellation of Options

23 Nov 2021 - Proposed issue of securities - IVX

23 Nov 2021 - Proposed issue of securities - IVX

23 Nov 2021 - Prospectus

22 Nov 2021 - Notification regarding unquoted securities - IVX

22 Nov 2021 - Share Purchase Plan Offer Booklet & Application Form

22 Nov 2021 - Section 708A Cleansing Statement

22 Nov 2021 - Application for quotation of securities - IVX

16 Nov 2021 - Proposed issue of securities - IVX

16 Nov 2021 - Proposed issue of securities - IVX

16 Nov 2021 - Proposed issue of securities - IVX

16 Nov 2021 - Capital Raising and expansion of Photosoft Territory

12 Nov 2021 - Trading Halt

9 Nov 2021 - Results of Annual General Meeting

9 Nov 2021 - AGM Presentation

1 Nov 2021 - Jobkeeper Payments Notice

October

29 Oct 2021 - Appointment of Company Secretary

29 Oct 2021 - Further Information on Proof of Concept Pilot Study

28 Oct 2021 - Complete Regression of TNBC Tumours and Protective Immunity

21 Oct 2021 - Activities Report and Appendix 4C

8 Oct 2021 - Grant of ASX Waiver

8 Oct 2021 - Notice of Annual General Meeting/Proxy Form

8 Oct 2021 - Change in substantial holding

6 Oct 2021 - Change of Director's Interest Notice- Robert Merriel

6 Oct 2021 - Section 708A Cleansing Statement

6 Oct 2021 - Change of Director's Interest Notice - Alistair Bennallack

6 Oct 2021 - Application for quotation of securities - IVX

4 Oct 2021 - Section 708A Cleansing Statement

4 Oct 2021 - Change of Director's Interest Notice- Robert Merriel

4 Oct 2021 - Application for quotation of securities - IVX

4 Oct 2021 - Application for quotation of securities - IVX

4 Oct 2021 - Change of Director's Interest Notice - Alistair Bennallack

4 Oct 2021 - Notification regarding unquoted securities - IVX

4 Oct 2021 - Change of Director's Interest Notice- Thian Chew

4 Oct 2021 - Notification regarding unquoted securities - IVX

September

23 Sep 2021 - Results of General Meeting

17 Sep 2021 - Change of Director's Interest Notice- Alan Yamashita

17 Sep 2021 - Change of Director's Interest Notice- Robert Merriel

17 Sep 2021 - Change of Director's Interest Notice- Thian Chew

17 Sep 2021 - Notification regarding unquoted securities - IVX

August

23 August 2021 - Notice of General Meeting

5 August 2021 - Securities Trading Policy

5 August 2021 - Appendix 4G and Corporate Governance Statement

5 August 2021 - Appendix 4E and Annual Report

July

22 July 2021 - Activities Report and Appendix 4C

9 July 2021 - CEO Contract

June

18 June 2021 - Change of Director's Interest Notice- Rob Merriel

11 June 2021 - Change of Director's Interest Notice- Alan Yamashita

11 June 2021 - Change of Director's Interest Notice- Rob Merriel

11 June 2021 - Change of Director's Interest Notice- Thian Chew

11 June 2021 - Notification regarding unquoted securities - IVX

9 June 2021 - Change of Director's Interest Notice- Rob Merriel

9 June 2021 - Section 708A Cleansing Statement opens new window

9 June 2021 - Application for quotation of securities - IVX

4 June 2021 - Change of Director's Interest Notice - Alistair Bennallack

2 June 2021 - Capital Raising & co-development for Photosoft Technology

May

31 May - Trading Halt

27 May 2021 - Release of securities from escrow

25 May 2021 - Initial Proof-of-Concept results show INV043 to be effective

April

27 April 2021 - Selection of New API (INV-043) and Next Steps in R&D Program

23 April 2021- Activities Report and Appendix 4C

13 April 2021 - Change of Director's Interest Notice- Rob Merriel

13 April 2021 - Section 708A Cleansing Statement

13 April 2021 - Appendix 2A

7 April 2021 - Change of Director's Interest Notice- Alan Yamashita

7 April 2021 - Change of Director's Interest Notice- Rob Merriel

7 April 2021 - Change of Director's Interest Notice- Thian Chew

7 April 2021 - Appendix 3G

February

25 February 2021 - App 4D and Financial Report for half year to 31 Dec 2020

22 February 2021 - Release of securities from escrow

January

21 January 2021 - Activities Report and Appendix 4C

18 January 2021 - Becoming a substantial holder

18 January 2021 - Change in substantial holdings

12 January 2021 - Change of Auditors

December

24 December 2020 -  Statement 708A Cleansing Statement

23 December 2020 - Change of Director's Interest Notice - Rob Merriel

23 December 2020 - Appendix 2A

15 December 2020 - Change of Director's Interest Notice - Thian Chew

15 December 2020 - Change of Director's Interest Notice - Rob Merriel

15 December 2020 - Change of Director's Interest Notice - Alan Yamashita

15 December 2020 - Appendix 3G

4 December 2020 - Distribution of shares by substantial shareholder

4 December 2020 - Lapse of unlisted options

November

23 November 2020 - Change of Director's Interest Notice - correction

5 November 2020 - Final Director's Interest Notice - Craig Newton

5 November 2020 - Lapse of unlisted options

5 November 2020 - Change of Director's Interest Notice - Craig Newton

5 November 2020 - Appendix 3G

5 November 2020 - Cleansing Notice and Appendix 2A

October

28 October 2020 - Change of Director's Interest Notice - Thian Chew

28 October 2020 - Change of Director's Interest Notice - Alan Yamashita

28 October 2020 - Appendix 3G

28 October 2020 - Appendix 3G

28 October 2020 - Initial Director's Interest Notice

26 October 2020 - Activities Report and Appendix 4C

26 October 2020 - Director Appointment

21 October 2020 - Results of Annual General Meeting

21 October 2020 - AGM Presentation

September

21 September 2020 - Grant of ASX Waiver

21 September 2020 - Proxy Form

21 September 2020 - Notice of Annual General Meeting

14 September 2020 - Appendix 3G - issue of options

2 September 2020 - Appendix 3G - issue of options

2 September 2020 - Initial Director's Interest Notice

1 September 2020 - Lapse of unlisted options

1 September 2020 - Final Director's Interest Notice

1 September 2020 - Director Appointment/Resignation

August

28 August 2020 - Appendix 4G and Corporate Governance Statement

26 August 2020 - Appendix 4E and Annual Report

12 August 2020 - Cleansing Notice and Appendix 2A

7 August 2020 - Change of Company Addresses

July

29 July 2020 - Business Update and Change to Board and Management

29 July 2020 - Activities Report and Appendix 4C June 2020 Quarter

13 July 2020 - Appointment of M Leydin as Chief Financial Officer

June

30 June 2020 - Invion subsidiary signs Supply Agreement with Pavay Biotech

23 June 2020 - Acceptance of New Zealand Patent Application

April

20 April 2020 - Program Update - March 2020 quarter

20 April 2020 - Appendix 4C - March 2020 quarter

15 April 2020 - Preliminary data links Photosoft with immune response

February

24 February 2020 - App 4D and Financial Report for half year to 31 Dec 2019

14 February 2020 - Photosoft data presented to Lorne Cancer Conference

5 February 2020 - Clarification to announcements of 3 February 2020

3 February 2020 - Lapse of unlisted share options

3 February 2020 - Invion signs R&D Services Agreement with Pavay Biotech

January

30 January 2020 - Appendix 4C December 2019 - cover note and market update

30 January 2020 - Appendix 4C - December 2019 quarter

9 January 2020 - App 3Z - Campbell - correction to date ceased to be director

 

 

December

24 December 2019 - MoU with Pavay on potential supply of dermatology compound

23 December 2019 - Final Directors Interest Notice - Campbell

23 December 2019 - Initial Directors Interest Notice - Farris

23 December 2019 - Change in Board and Management

November

29 November 2019 - Additional Information to Prior Announcement

27 November 2019 - Photosoft technology shrinks ovarian cancer in vivo

4 November 2019 - App 3X - Initial Directors Interest Notice - C Newton

4 November 2019 - App 3Z - Director's Final Interests Notice - G Collier

4 November 2019 - Results of AGM

4 November 2019 - App 3Y - Change of Directors Interest Notice - G Collier

4 November 2019 - Chairman's Address and CEO Presentation to Board

October

31 October 2019 - Appendix 3B - issue of options to incoming CEO

31 October 2019 - Pre-clinical research agreement with Peter MacCallum CC

29 October 2019 - Appendix 4C - September 2019 quarter

24 October 2019 - C Newton to commence as CEO - Material terms of appointment

3 October 2019 - AGM Notice of Meeting

September

30 September 2019 - Investor Update - September 2019

30 September 2019 - Invion optimises PDT therapy and laser for 2020 human trials

August

28 August 2019 - Corporate Governance Statement

28 August 2019 - Appendix 4G

28 August 2019 - Appendix 4E and Financial Report for year ended 30 June 2019

15 August 2019 - Change in substantial holding

July

22 July 2019 - COO Craig Newton to transition to Invion CEO

12 July 2019 - Appendix 4C - June quarter

May

28 May 2019 - Animal studies show IVX-P02 potential in metastatic cancers

April

18 April 2019 - Quarterly Update

18 April 2019 - Appendix 4C - March 2019 quarter

1 April 2019 - Response to ASX Price Query

February

28 February 2019 - Corporate update to support BD and investor meetings

28 February 2019 - Corporate Update and Investor Presentation - Q1 2019

26 February 2019 - Appendix 4D and Financial Report for Half Year to 31 Dec 18

21 February 2019 - Shareholder Q&A on spinout of Chronic Airway Therapeutics

21 February 2019 - Response to ASX Appendix 4C Query

18 February 2019 - App 3Y Change in Director Interests - T Chew

18 February 2019 - App 3Y Change in Director Interests - G Collier

18 February 2019 - App 3Y Change in Director Interests - J Campbell

18 February 2019 - App 3X Initial Directors Interest Notice - A Yamashita

18 February 2019 - App 3Z Final Directors Interest Notice - M Glass

12 February 2019 - Appendix 3B - issue of shares and unlisted share options

12 February 2019 - Invion completes spin-out of respiratory assets

January

30 January 2019 - General Meeting - Results of Meeting

30 January 2019 - CEO Update to General Meeting

29 January 2019 - Invion selects Guilin Xingda for light-therapy manufacture

29 January 2019 - Appendix 4C - December quarter

16 January 2019 - Invion appoints cancer experts to Scientific Advisory Board

December

24 December 2018 - Appendix 3Y - Change in Director Interests - Thian Chew

21 December 2018 - General Meeting - Notice of Meeting

21 December 2018 - Respiratory Assets Demerger - Receipt of draft Class Ruling

14 December 2018 - Appendix 3Y - Change in Director Interests - Thian Chew

November

29 November 2018 - Demerger of respiratory assets - update

19 November 2018 - Ceasing to have an interest over shares

19 November 2018 - Appendix 3B - lapse of unlisted share options

19 November 2018 - Notification regarding release of escrowed securities

16 November 2018 - Invion Constitution adopted 13 November 2018

13 November 2018 - Annual General Meeting - Results of Meeting

13 November 2018 - Chairman's Address and CEO Presentation to AGM

7 November 2018 - Invion collaborates to develop powerful skin cancer gel

October

29 October 2018 - Appendix 4C - September 2018 quarter

September

27 September 2018 - CAT appoints R&G Pharma as CRO for nadolol in China

25 September 2018 - New Photosoft formulation increased effect in ovarian cancer

24 September 2018 - AGM Notice of Meeting

10 September 2018 - Photosoft granted Australian patent and Business Update

7 September 2018 - Demerger - clarification on eligible shareholders

5 September 2018 - Spin out of respiratory assets for development in China

August

28 August 2018 - Highlights of financial and operating results for FY2018

28 August 2018 - Corporate Governance Statement

28 August 2018 - Appendix 4G - Key to Governance Disclosures

28 August 2018 - Appendix 4E Annual Report and Full Year Statutory Accounts

July

27 July 2018 - Appendix 4C - June 2018 quarter

5 July 2018 - Photosoft efficiently destroys ovarian cancer cells in vitro

May

29 May 2018 - Appendix 3B - shares issued upon exercise of options

22 May 2018 - Appendix 3B - shares issued on exercise of options

14 May 2018 - Appendix 3B - issue of shares following options exercise

10 May 2018 - Appendix 3B - issue of shares following options exercise

April

30 April 2018 - Shareholder Newsletter

30 April 2018 - Appendix 3B - issue of shares following options exercise

26 April 2018 - App 3B - issue of 10M shares following option exercise

26 April 2018 - Appendix 4C - March 2018 quarter

19 April 2018 - App 3B - issue of 2M shares following option exercise

18 April 2018 - Appendix 3Y - change to director interests Mitchell Glass

17 April 2018 - Appendix 3B - unlisted share options

March

29 March 2018 - Response to ASX Price Query

22 March 2018 - Final Director's Interest Notice

22 March 2018 - Change to Board of Invion - retirement of Mr Warren Brown

21 March 2018 - Appointment of Dr Andrew Stephens to Advisory Board

20 March 2018 - Invion alliance with Hudson Institute of Medical Research

19 March 2018 - Appendix 3Y - Chew

19 March 2018 - Appendix 3Y - Collier

19 March 2018 - Appendix 3Y - Campbell

19 March 2018 - Appendix 3Y - Brown

16 March 2018 - Change of Registered Address and Principal Place of Business

15 March 2018 - Appendix 3B - allotment of Rights Issue Shares

13 March 2018 - Completion of Rights Issue

1 March 2018 - Response to ASX Price Query

 

28 February 2018 - Appendix 4D and Financial Report for half year to 31 Dec 17

20 February 2018 - Notice of despatch of Rights Issue documentation

12 February 2018 - Rights Issue - Notice to option holders

12 February 2018 - Rights Issue - Notice to ineligible shareholders

12 February 2018 - Rights Issue - Notice to eligible shareholders

12 February 2018 - Appendix 3B - for quotation of Rights Issue shares

12 February 2018 - Rights Issue Information Booklet

12 February 2018 - Invion announces underwritten Right Issue

12 February 2018 - Corporate presentation - February 2018

12 February 2018 - Cleansing Notice - Rights Issue

8 February 2018 - Response to ASX Price Query

January

29 January 2018 - Appendix 4C - December 2017 Quarter

2 January 2018 - Notice of initial substantial holder- UIG Limited